Effects of androgens on telomerase activity in normal and malignant prostate cells in vitro

Prostate

Volumn 43, Issue 3, 2000, Pages 161-168

  Soda, Hiroshi ^a,b   Raymond, Eric ^a   Sharma, Sunil ^a   Lawrence, Richard ^a   Davidson, Karen ^a   Oka, Mikio ^b   Kohno, Shigeru ^b   Izbicka, Elzbieta ^a   Von Hoff, Daniel D ^a  

^a CTRC Institute for Drug Development   (United States)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell cycle; LNCaP cells; Telomerase regulation; Testosterone

Indexed keywords

ANDROGEN; ANDROSTANOLONE; HYDROXYUREA; TELOMERASE;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE G1 PHASE; CONTROLLED STUDY; ENZYME ACTIVITY; HORMONAL REGULATION; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE;

ANDROGENS; CELL CYCLE; DIHYDROTESTOSTERONE; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 0034110338     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(20000515)43:3<161::AID-PROS1>3.0.CO;2-O     Document Type: Article

References (27)

1. Sharma S, Raymond E, Soda H, Sun D, Hilsenbeck SG, Sharma A, Izbicka E, Windle B, Von Hoff DD. Preclinical and clinical strategies for development of telomerase and telomere inhibitors. Ann Oncol 1997;8:1063-1074.
2. Sommerfeld H-J, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey DS. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 1996;56:218-222.
3. Lin Y, Uemura H, Fujinami K, Hosaka M, Harada M, Kubota Y. Telomerase activity in primary prostate cancer. J Urol 1997;157: 1161-1165.
4. Belair CD, Yeager TR, Lopez PM, Reznikoff CA. Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA 1997;94:13677-13682.
5. Banerjee PP, Banerjee S, Zirkin BR, Brown TR. Lobe-specific telomerase activity in the intact adult brown Norway rat prostate and its regional distribution within the prostatic ducts. Endocrinology 1998;139:513-519.
6. Tsao J-L, Zhao Y, Lukas J, Yang X, Shah A, Press M, Shibata D. Telomerase activity in normal and neoplastic breast. Clin Cancer Res 1997;3:627-631.
7. Tanaka M, Kyo S, Takakura M, Kanaya T, Sagawa T, Yamashita K, Okada Y, Hiyama E, Inoue M. Expression of telomerase activity in human endometrium is localized to epithelial glandular cells and regulated in a menstrual phase-dependent manner correlated with cell proliferation. Am J Pathol 1998;153:1985-1991.
8. Yang Y, Hao J, Liu X, Dalkin B, Nagle RB. Differential expression of cytokeratin mRNA and protein in normal prostate, prostatic intraepithelial neoplasia, and invasive carcinoma. Am J Pathol 1997;150:693-704.
9. Holt SE, Norton JC, Wright WE, Shay JW. Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRA-Peze telomerase detection kit. Methods Cell Sci 1996;18:237-248.
10. Sun D, Lopez-Guajardo CC, Quada J, Hurley LH, Von Hoff DD. Regulation of catalytic activity and processivity of human telomerase. Biochemistry 1999;38:4037-4044.
11. Izbicka E, Wheelhouse RT, Raymond E, Davidson KK, Lawrence RA, Sun D, Windle BE, Hurley LH, Von Hoff DD. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. Cancer Res 1999;59:639-644.
12. Raymond E, Sun D, Izbicka E, Mangold G, Silvas E, Windle B, Sharma S, Soda H, Lawrence R, Davidson K, Von Hoff DD. A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay. Br J Cancer 1999;80:1332-1341.
13. Sharma S, Raymond E, Soda H, Izbicka E, Davidson K, Lawrence R, Von Hoff DD. Dimethyl sulfoxide (DMSO) causes a reversible inhibition of telomerase activity in a Burkitt lymphoma cell line. Leuk Res 1998;22:663-670.
14. Kageyama Y, Kamata S, Yonese J, Oshima H. Telomere length and telomerase activity in bladder and prostate cancer cell lines. Int J Urol 1997;4:407-410.
15. Van Steensel B, De Lange T. Control of telomere length by the human telomeric protein TRF1. Nature 1997;385:740-743.
16. Saeed B, Zhang H, Ng S-C. Apoptotic program is initiated but not completed in LNCaP cells in response to growth in charcoal-stripped media. Prostate 1997;31:145-152.
17. Holt SE, Aisner DL, Shay JW, Wright WE. Lack of cell cycle regulation of telomerase activity in human cells. Proc Natl Acad Sci USA 1997;94:10687-10692.
18. Landberg G, Nielsen NH, Nilsson P, Emdin SO, Cajander J, Roos G. Telomerase activity is associated with cell cycle deregulation in human breast cancer. Cancer Res 1997;57:549-554.
19. Balasubramanian S, Kim K-H, Ahmad N, Mukhtar H. Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouse. Oncogene 1999;18:1297-1302.
20. Perry JE, Tindall DJ. Androgens regulate the expression of proliferating cell nuclear antigen posttranscriptionally in the human prostate cancer cell line, LNCaP. Cancer Res 1996;56:1539-1544.
21. Lee C, Sutkowski DM, Sensibar JA, Zelner D, Kim I, Amsel I, Shaw N, Prins GS, Kozlowski JM. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone. Endocrinology 1995;136:796-803.
22. Kim IY, Kim J-H, Zelner DJ, Ahn H-J, Sensibar JA, Lee C. Transforming growth factor-β1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP. Endocrinology 1996;137:991-999.
23. Bonkhoff H, Remberger K. Differentiation pathways and histogenetic aspects of normal and abnormal prostate growth: a stem cell model. Prostate 1996;28:98-106.
24. Meeker AK, Sommerfeld HJ, Coffey DS. Telomerase is activated in the prostate and seminal vesicles of the castrated rat. Endocrinology 1996;137:5743-5746.
25. Fong C-J, Sherwood ER, Sutkowski DM, Abu-Jawdeh GM, Yokoo H, Bauer KD, Kozlowski JM, Lee C. Reconstituted basement membrane promotes morphological and functional differentiation of primary human prostatic epithelial cells. Prostate 1991; 19:221-235.
26. Craft N, Chhor C, Tran C, Belldegrun A, DeKernion J, Witte ON, Said J, Reiter RE, Sawyers CL. Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. Cancer Res 1999; 59:5030-5036.
27. Bui M, Reiter RE. Stem cell genes in androgen-independent prostate cancer. Cancer Metastasis Rev 1999;17:391-399.